Sagimet Biosciences Inc.（SGMT）内部人交易：高管与董事近期交易
过去 18 个月，共有 5 位内部人为 Sagimet Biosciences Inc.（SGMT）报告了 22 笔 Form 4 交易（最近一笔 2026-08-17）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-17 | Kemble George | 董事 | 买入 | 326,618 | $2.1M |
| 2026-08-17 | Kemble George | 董事 | 买入 | 24,369 | $154,987 |
| 2026-08-17 | Kemble George | 董事 | 卖出 | 350,987 | $3.6M |
| 2026-08-12 | Kemble George | 董事 | 买入 | 9,751 | $62,016 |
| 2026-08-12 | Kemble George | 董事 | 买入 | 10,455 | $66,494 |
| 2026-08-12 | Kemble George | 董事 | 卖出 | 20,206 | $201,147 |
| 2026-07-22 | Happel David | President & CEO | 卖出 | 64,051 | $497,068 |
| 2026-07-22 | Kemble George | 董事 | 卖出 | 18,844 | $140,529 |
| 2026-07-22 | Rozek Elizabeth | Chief Legal & Admin. Officer | 卖出 | 10,545 | $81,832 |
| 2026-02-20 | Chauche Thierry | Chief Financial Officer | 买入 | 44,000 | $0 |
| 2026-02-20 | Happel David | President & CEO | 买入 | 128,000 | $0 |
| 2026-02-20 | Rozek Elizabeth | Chief Legal & Admin. Officer | 买入 | 44,000 | $0 |
| 2026-02-20 | Martins Eduardo Bruno | Chief Medical Officer | 买入 | 44,000 | $0 |
| 2026-02-12 | Happel David | President & CEO | 卖出 | 12,101 | $64,861 |
| 2026-02-12 | Martins Eduardo Bruno | Chief Medical Officer | 卖出 | 3,640 | $19,510 |
| 2026-02-12 | Rozek Elizabeth | Chief Legal & Admin. Officer | 卖出 | 2,622 | $14,054 |
| 2026-02-12 | Chauche Thierry | Chief Financial Officer | 卖出 | 1,312 | $7,032 |
| 2025-11-21 | Kemble George | Executive Chairman | 卖出 | 37,688 | $289,821 |
| 2025-11-06 | Rozek Elizabeth | Chief Legal & Admin. Officer | 买入 | 9,855 | $0 |
| 2025-07-23 | Happel David | President & CEO | 卖出 | 65,478 | $597,814 |
| 2025-07-23 | Rozek Elizabeth | General Counsel and CCO | 卖出 | 10,780 | $98,421 |
| 2025-07-23 | Martins Eduardo Bruno | Chief Medical Officer | 卖出 | 8,277 | $75,569 |
来源：SEC Form 4 申报文件 · 截至 2026-08-17